NCT01426139View on ClinicalTrials.gov

BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

February 28, 2013

Conditions
Coronary Artery Disease
Interventions
DEVICE

Percutaneous Coronary Intervention Biotronik Orsiro DES

Stenting

Trial Locations (4)

110017

Max Super Speciality Hospital, New Delhi

110025

Fortis Escorts Heart Institute and Research Centre, New Delhi

122001

Medanta The Medicity Hospital, Gūrgaon

600037

Madras Medical Mission, Chennai

Sponsors

Lead Sponsor

Biotronik AG
All Listed Sponsors
lead

Biotronik AG

INDUSTRY

NCT01426139 - BIOFLOW-INDIA Safety and Clinical PerFormance of the Drug Eluting ORSIRO Stent in Single de Novo Coronary Artery Lesions | Biotech Hunter | Biotech Hunter